Use of parecoxib by continuous subcutaneous infusion for cancer pain in a hospice population

OBJECTIVES: To characterise the use of the parenteral non-steroidal anti-inflammatory drug parecoxib when given by continuous subcutaneous infusion (CSCI) in a hospice population. Clinical experience suggests parecoxib CSCI may be of benefit in this population, but empirical evidence in relation to...

Descripción completa

Detalles Bibliográficos
Autores principales: Armstrong, Peter, Wilkinson, Pauline, McCorry, Noleen K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867430/
https://www.ncbi.nlm.nih.gov/pubmed/28864447
http://dx.doi.org/10.1136/bmjspcare-2017-001348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867430/
https://www.ncbi.nlm.nih.gov/pubmed/28864447
http://dx.doi.org/10.1136/bmjspcare-2017-001348

Ejemplares similares